CA3045144C - Composition de microparticules erythrocytaires et procedes d'utilisation de celle-ci - Google Patents

Composition de microparticules erythrocytaires et procedes d'utilisation de celle-ci

Info

Publication number
CA3045144C
CA3045144C CA3045144A CA3045144A CA3045144C CA 3045144 C CA3045144 C CA 3045144C CA 3045144 A CA3045144 A CA 3045144A CA 3045144 A CA3045144 A CA 3045144A CA 3045144 C CA3045144 C CA 3045144C
Authority
CA
Canada
Prior art keywords
composition
rmps
rmp
blood cells
red blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3045144A
Other languages
English (en)
Other versions
CA3045144A1 (fr
Inventor
Yeon S. Ahn
Wenche Jy
Lawrence L. Horstman
Rifat Pamukcu
Original Assignee
Rxmp Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rxmp Therapeutics Inc filed Critical Rxmp Therapeutics Inc
Priority claimed from PCT/US2017/063700 external-priority patent/WO2018102409A2/fr
Publication of CA3045144A1 publication Critical patent/CA3045144A1/fr
Application granted granted Critical
Publication of CA3045144C publication Critical patent/CA3045144C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne une composition comprenant des microparticules érythrocytaires (MPGR) présentant des caractéristiques avantageuses sur le plan clinique.
CA3045144A 2016-11-30 2017-11-29 Composition de microparticules erythrocytaires et procedes d'utilisation de celle-ci Active CA3045144C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662428155P 2016-11-30 2016-11-30
US62/428,155 2016-11-30
PCT/US2017/063700 WO2018102409A2 (fr) 2016-11-30 2017-11-29 Composition de microparticules érythrocytaires et procédés d'utilisation de celle-ci

Publications (2)

Publication Number Publication Date
CA3045144A1 CA3045144A1 (fr) 2018-06-07
CA3045144C true CA3045144C (fr) 2026-01-27

Family

ID=

Similar Documents

Publication Publication Date Title
AU2005272821B2 (en) Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use
JP2011184465A (ja) 止血を促進するためのフィブリノゲン標的微粒子
JP2007507480A5 (fr)
Pitkänen et al. Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma
Pandit et al. Blood component support in acquired coagulopathic conditions: is there a method to the madness?
JP2014506569A (ja) 出血の処置のための赤血球由来微粒子（ｒｍｐ）の拡大された有用性
CN106413744B (zh) 用于在出血性疾病治疗中改善止血的人凝血酶原和活化的因子x的组合物
CA3045144C (fr) Composition de microparticules erythrocytaires et procedes d'utilisation de celle-ci
AU2017367084B2 (en) RMP composition and methods of use
O'Reilly et al. Acquired hemophilia, meningioma, and diphenylhydantoin therapy
HK40014174A (en) Rmp composition and methods of use
HK40014174B (en) Rmp composition and methods of use
CA2431332A1 (fr) Compositions et methodes permettant de prolonger la survie de plaquettes refrigerees
McMillan et al. Acquired coagulation disorders in children
Banini et al. Coagulopathy: Pathophysiology, Evaluation, and Treatment
Lin et al. Inhibiting thromboinflammation via interleukin-4 binding to platelet glycoprotein VI and suppression of thrombosis
AU2016273842A1 (en) Methods for Treating Bleeding Disorders Using a Platelet Subpoulation
Agostini et al. Blood Products, Derivates, and Prohemostatic Drugs
Ciesla Quantitative and qualitative platelet disorders
Hiller Bleeding disorders
Bergs Update, edit and revision of the medical laboratory technician program class notes to reflect current practices in the study of coagulation
Yoo et al. Coagulation abnormalities made easy
Cox The Development of an Assay to Evaluate the Efficacy of a Novel GPIb Antagonist, and the Functional Characterisation of the Drug
Kappus et al. Coagulopathy: Pathophysiology, Evaluation, and Treatment